By Matt Jones

NEW YORK (GenomeWeb News) – Life sciences companies have mixed opinions on how the US Food and Drug Administration is faring in its efforts to keep up with innovations such as personalized medicine and about the extent communication with the agency is helping to bring new drugs and medical devices to market more swiftly, according to a new industry survey.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.